Cheung Chui Ming Gemmy, Yang Elizabeth, Lee Won Ki, Lee Gary K Y, Mathur Ranjana, Cheng Jacob, Wong Doric, Wong Tien Yin, Lai Timothy Y Y
Medical Retina Service, Singapore National Eye Centre, Singapore, Singapore.
Eye Academic Clinical Program, Duke-NUS Graduate Medical School, Singapore, Singapore.
Graefes Arch Clin Exp Ophthalmol. 2015 Dec;253(12):2075-85. doi: 10.1007/s00417-015-2933-2. Epub 2015 Jan 27.
We aimed to evaluate the long-term natural history of polypoidal choroidal vasculopathy (PCV) in untreated patients.
This is a retrospective observational case series. Patients with symptomatic PCV who did not receive any treatment for at least 12 months were included from the records of three ophthalmic clinics in Asia. The medical records and imaging data were reviewed. Visual outcomes at month 12 and at last follow-up were analyzed. The influence of demographics and presenting features on visual outcome was analyzed.
A total of 32 eyes (32 patients) were included in this analysis. The mean follow-up was 59.9 months (range, 18-119 months), the mean age was 65.7 years and 21 (65.6 %) patients were male. The mean presenting logMAR visual acuity was 0.79 (Standard deviation [SD] 0.49). The center of the fovea was involved by the PCV complex in 25 eyes (78.1 %). The mean greatest linear dimension (GLD) of the PCV complex was 2584 μm (SD 880). Twenty-three eyes (71.9 %) had a cluster-of-grapes configuration on indocyanine green angiography. Leakage of fluorescein angiography was present in 29 eyes (90.6 %). The mean logMAR vision deteriorated from 0.79 at baseline to 0.88 at month 12 (p = 0.11), and further to 1.14 (p = 0.003) at the last follow-up. The proportion of eyes that improved, remained unchanged and worsened was 21.9 %, 31.3 % and 46.9 %, respectively, at month 12; and 28.1 %, 9.4 % and 62.5 %, respectively, at last follow-up. The proportion of eyes with logMAR vision worse than 1.0 was 28.1 % at presentation, and increased to 31.3 % at month 12 and further to 53.1 % at last follow-up. Reasons for poor vision were due to retinal, subretinal or vitreous hemorrhage, and retinal pigment epithelium (RPE) atrophy and scarring. None of the presenting features were found to significantly influence visual outcome.
Half of eyes presenting with symptomatic PCV had a relatively benign course without treatment and some even had vision improvement. However, in the remaining eyes, vision deteriorated significantly, mainly due to hemorrhage and scarring. There may be subtypes of PCV with divergent natural history.
我们旨在评估未经治疗的息肉状脉络膜血管病变(PCV)患者的长期自然病程。
这是一项回顾性观察性病例系列研究。从亚洲三家眼科诊所的记录中纳入至少12个月未接受任何治疗的有症状PCV患者。对病历和影像数据进行回顾。分析第12个月和最后一次随访时的视力结果。分析人口统计学和呈现特征对视力结果的影响。
本分析共纳入32只眼(32例患者)。平均随访时间为59.9个月(范围18 - 119个月),平均年龄为65.7岁,21例(65.6%)为男性。初始呈现的logMAR视力平均值为0.79(标准差[SD]0.49)。25只眼(78.1%)的黄斑中心凹被PCV复合体累及。PCV复合体的平均最大线性尺寸(GLD)为2584μm(SD 880)。23只眼(71.9%)在吲哚青绿血管造影上呈葡萄串样形态。29只眼(90.6%)存在荧光素血管造影渗漏。平均logMAR视力从基线时的0.79恶化至第12个月时的0.88(p = 0.11),并在最后一次随访时进一步恶化至1.14(p = 0.003)。在第12个月时,视力改善、不变和恶化的眼的比例分别为21.9%、31.3%和46.9%;在最后一次随访时,分别为28.1%、9.4%和62.5%。初始logMAR视力大于1.0的眼的比例在初诊时为28.1%,在第12个月时增至31.3%,在最后一次随访时进一步增至53.1%。视力不佳的原因是视网膜、视网膜下或玻璃体出血以及视网膜色素上皮(RPE)萎缩和瘢痕形成。未发现任何呈现特征对视力结果有显著影响。
一半有症状的PCV患者未经治疗病程相对良性,有些甚至视力改善。然而,在其余的眼中,视力显著恶化,主要是由于出血和瘢痕形成。PCV可能存在自然病程不同的亚型。